Drug Discovery · Oxford, United Kingdom · Founded 2020 · Privately Held (backing)
Developer of a cell discovery platform designed to accelerate the development of new targets for chimeric antigen receptors. Coding Bio is based in Oxford, United Kingdom and was founded in 2020. It was valued at $6.6 million at its seed round in Sep 2023, the last priced event on record. It has raised $3.6 million across 1 recorded round; the latest was a $3.6 million seed round in Sep 2023.
PMV mark · valuation
$6.6M
Oct 2026
Priced at
its seed round
Sep 2023
Total raised
$3.6M
Last round
Seed Round
Sep 2023
Team — not yet on record
No current team members for Coding Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Coding Bio with a free account
·The complete investor list: 15 names
·Watch Coding Bio: the Monday email on marks, rounds and moves